Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiL (Journal of Clinical Oncology (2009) 27, (1227-1234))

Journal of Clinical Oncology

Volumn 27, Issue 14, 2009, Pages 2415-

  Reck, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 72949090330     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.1373     Document Type: Erratum

References (0)